The study reveals that a significant portion of medicines, especially antimalarials, antibiotics, and antiretrovirals, are of compromised quality, posing grave health risks and economic burdens. Factors contributing to this include weak regulatory oversight, insufficient post-market surveillance, and supply chain challenges. The article underscores the urgency for Cameroon to strengthen its regulatory A1:G46 raise public awareness, and foster collaborations to ensure medicine quality, thereby safeguarding public health and achieving better health outcomes for its citizens.
You can submit a specific query to QUAMED experts by clicking on the button below. We will send relevant answers directly to your mailbox.
Submit Query
The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.
ISO 9001:2015 - FS766975
© 2025 - QUAMED
Content of this site is licensed under a Creative Commons License- BY Attribution